Potentiation of epidermal growth factor-mediated oncogenic transformation by sialidase NEU3 leading to src activation

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Yamamoto, Koji ^a,d   Takahashi, Kohta ^a   Shiozaki, Kazuhiro ^b   Yamaguchi, Kazunori ^c   Moriya, Setsuko ^a   Hosono, Masahiro ^a   Shima, Hiroshi ^d   Miyagi, Taeko ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c MIYAGI CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; EPIDERMAL GROWTH FACTOR; GANGLIOSIDE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; SIALIDASE; SIALIDASE NEU3; UNCLASSIFIED DRUG; EPIDERMAL GROWTH FACTOR RECEPTOR; NEU3 PROTEIN, HUMAN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CLONOGENESIS; COLONY FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FIBROBLAST; GENE ACTIVATION; GENE OVEREXPRESSION; GENETIC TRANSFORMATION; IMMUNOPRECIPITATION; IN VIVO STUDY; MALE; MOUSE; NEU3 GENE; NIH 3T3 CELL; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STABLE TRANSFECTION; TUMOR GENE; TUMOR GROWTH; UPREGULATION; VECTOR CONTROL; 3T3 CELL LINE; ANIMAL; BAGG ALBINO MOUSE; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; NUDE MOUSE; PATHOLOGY;

MUS MUSCULUS;

ANIMALS; CARCINOGENESIS; CELL PROLIFERATION; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; GANGLIOSIDES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEURAMINIDASE; NIH 3T3 CELLS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TRANSFECTION; UP-REGULATION;

EID: 84925763440     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120578     Document Type: Article

References (37)

1. Lau KS, Dennis JW. N-Glycans in cancer progression. Glycobiology. 2008; 18:750-760. doi: 10.1093/ glycob/cwn071 PMID: 18701722
2. Hakomori SI. Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motility. FEBS Lett. 2010; 584:1901-1906. doi: 10.1016/j.febslet.2009.10.065PMID: 19874824
3. Miyagi T, Yamaguchi K. Mammalian sialidases: physiological and pathological roles in cellular functions. Glycobiology. 2012; 22:880-896. doi: 10.1093/glycob/cws057 PMID: 22377912
4. Miyagi T, Wada T, Yamaguchi K, Hata K, Shiozaki K. Plasma membrane- associated sialidase as a crucial regulator of transmembrane signaling. J Biochem. 2008; 144, 279-285. doi: 10.1093/jb/mvn089 PMID: 18632803
5. Miyagi T, Takahashi K, Hata K, Shiozaki K, Yamaguchi K. Sialidase significance for cancer progression. Glycoconjugate. 2012; J 29:567-577. doi: 10.1007/s10719-012-9394-1 PMID: 22644327
6. Kakugawa Y, Wada T, Yamaguchi K, Yamanami H, Ouchi K, Sato I, et al. Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression. Proc Natl Acad Sci USA. 2002; 99:10718-10723. PMID: 12149448
7. Ueno S, Saito S, Wada T, Yamaguchi K, Satoh M, Arai Y, et al. Plasma membrane-associated sialidase is up-regulated in renal cell carcinoma and promotes interleukin-6-induced apoptosis suppression and cell motility. J Biol Chem. 2006; 281:7756-7764. PMID: 16428383
8. Kawamura S, Sato I, Wada T, Yamaguchi K, Li Y, Li D, et al. Plasma membrane-associated sialidase (NEU3) regulates progression of prostate cancer to androgen-independent growth through modulation of androgen receptor signaling. Cell Death Differ. 2012; 19:170-179. doi: 10.1038/cdd.2011.83 PMID: 21681193
9. Nomura H, Tamada Y, Miyagi T, Suzuki A, Taira M, Suzuki N, et al. Expression of NEU3 (plasma mem-brane-associated sialidase) in clear cell adenocarcinoma of the ovary: its relationship with T factor of pTNM classification. Oncol Res 2006; 16: 289-297. PMID: 17476974
10. Yamaguchi K., Koseki K., Shiozaki M., Shimada Y., Wada T, et al. Regulation of plasma membrane-associated sialidase NEU3 gene by Sp1/Sp3 transcription factors. Biochem, J. 2010; 430: 107-117. doi: 10.1042/BJ20100350 PMID: 20518744
11. Wada T, Hata K, Yamaguchi K, Shiozaki K, Koseki K, Moriya S, et al. A crucial role of plasma mem-brane-associated sialidase in the survival of human cancer cells. Oncogene. 2008; 26:2483-2490.
12. Kato K, Shiga K, Yamaguchi K, Hata K, Kobayashi T, Miyazaki K, et al. Plasma membrane-associated sialidase (NEU3) differentially regulates integrin-mediated cell proliferation through laminin- and fibro-nectin-derived signalling. Biochem J. 2006; 394: 647-56. PMID: 16241905
13. Shiozaki K, Yamaguchi K, Sato I, Miyagi T. Plasma membrane-associated sialidase (NEU3) promotes formation of colonic aberrant crypt foci in azoxymethane-treated transgenic mice. Cancer Sci. 2009; 100:588-594. doi: 10.1111/j.1349-7006.2008.01080.x PMID: 19215228
14. Yamaguchi K, Shiozaki K, Moriya S, Koseki K, Wada T, Tateno H, et al. Reduced susceptibility to coli-tis-associated colon carcinogenesis in mice lacking plasma membrane-associated sialidase. PLoS One. 2012; 7:e41132 doi: 10.1371/journal.pone.0041132 PMID: 22815940
15. Baselga J1, Arteaga CL. Critical update and emerging trends in epidermal growth factor receptor targeting in cancer. J Clin Oncol. 2005; 23:2445-59 PMID: 15753456
16. Ishizawar R, Parsons S. c-Src and cooperating partners in human cancer. Cancer Cell. 2004; 6, 209-214 PMID: 15380511
17. Wada T., Yoshikawa Y., Tokuyama S., Kuwahara M., Akita H., Miyagi T. Cloning, expression and chromosomal mapping of a human ganglioside sialidase. Biochem Biophys Res Commun. 1999; 261, 21-27. PMID: 10405317
18. Kitamura T, Koshino Y, Shibata F, Oki T, Nakajima H, Nosaka T, et al. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp Hematol. 2003; 31: 1007-1014. PMID: 14585362
19. Wang Y, Yamaguchi K, Shimada Y, Zhao X, Miyagi T. Site-directed mutagenesis of human membraneassociated ganglioside sialidase: identification of amino-acid residues contributing to substrate specificity. Eur J Biochem. 2001; 268: 2201-2208. PMID: 11298736
20. Wang Y, Yamaguchi K, Wada T, Hata K, Zhao X, Fujimoto T, et al. A close association of the ganglio-side-specific sialidase Neu3 with caveolin in membrane microdomains. J Biol Chem. 2002; 277:26252-26259. PMID: 12011038
21. Kato T, Wang Y, Yamaguchi K, Milner CM, Shineha R, Satomi S, et al. Overexpression of lysosomaltype sialidase leads to suppression of metastasis associated with reversion of malignant phenotype in murine B16 melanoma cells. Int J Cancer. 2001; 92:797-804. PMID: 11351298
22. Shih C, Padhy LC, Murray M, Weinberg RA. Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature. 1981; 290: 261-264. PMID: 7207618
23. Velu TJ1, Beguinot L, Vass WC, Willingham MC, Merlino GT, Pastan I, et al. Epidermal-growth-factordependent transformation by a human EGF receptor proto-oncogene. Science. 1987; 238:1408-1410.PMID: 3500513
24. Tsutsumi O, Kurachi H, Oka T. A physiological role of epidermal growth factor in male reproductive function. Science. 1986; 233: 975-977. PMID: 3090686
25. Tice DA, Biscardi JS, Nickles AL, Parsons SJ. Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proc Natl Acad Sci U S A. 1999; 96:1415-1420. PMID: 9990038
26. Parsons SJ, Parsons JT. Src family kinases, key regulators of signal transduction. Oncogene. 2004; 23; 7906-7909. PMID: 15489908
27. Albohy A, Li MD, Zheng RB, Zou C, Cairo CW. Insight into substrate recognition and catalysis by the human neuraminidase 3 (NEU3) through molecular modeling and site-directed mutagenesis. Glycobiology. 2010; 20:1127-1138. doi: 10.1093/glycob/cwq077 PMID: 20511247
28. Yoon SJ, Nakayama K, Hikita T, Handa K, Hakomori SI. Epidermal growth factor receptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptor. Proc Natl Acad Sci U S A. 2006; 103:18987-18991. PMID: 17142315
29. Kawashima N1, Yoon SJ, Itoh K, Nakayama K. Tyrosine kinase activity of epidermal growth factor receptor is regulated by GM3 binding through carbohydrate to carbohydrate interactions. J Biol Chem. 2009; 284:6147-6155. doi: 10.1074/jbc.M808171200 PMID: 19124464
30. Coskun Ü, Grzybek M, Drechsel D, Simons K. Regulation of human EGF receptor by lipids. Proc Natl Acad Sci U S A. 2011; 108:9044-8. doi: 10.1073/pnas.1105666108 PMID: 21571640
31. Greulich H, Chen TH, Feng W, Jänne PA, Alvarez JV, Zappaterra M, et al. Oncogenic transformation by inhibitor-sensitive and-resistant EGFR mutants. PLoS Med. 2005; 2:e313. PMID: 16187797
32. Chung BM, Dimri M, George M, Reddi AL, Chen G, et al. The role of cooperativity with Src in oncogenic transformation mediated by non-small cell lung cancer-associated EGF receptor mutants. Oncogene. 2009; 28:1821-1832. doi: 10.1038/onc.2009.31 PMID: 19305428
33. Miljan EA, Meuillet EJ, Mania-Farnell B, George D, Yamamoto H, Simon HG, et al. Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides. J Biol Chem. 2002; 277:10108-10113. PMID: 11796728
34. Red Brewer M, Choi SH, Alvarado D, Moravcevic K, Pozzi A, Lemmon MA, et al. The juxtamembrane region of the EGF receptor functions as an activation domain. Mol Cell. 2009; 34:641-651. doi: 10. 1016/j.molcel.2009.04.034 PMID: 19560417
35. Jura N, Endres NF, Engel K, Deindl S, Das R, Lamers MH, et al. Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment. Cell. 2009; 137:1293-1307. doi: 10.1016/j. cell.2009.04.025 PMID: 19563760
36. Wang XQ, Sun P, Paller AS. Ganglioside induces caveolin-1 redistribution and interaction with the epidermal growth factor receptor. J Biol Chem. 2002; 277: 47028-47034. PMID: 12354760
37. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006; 127: 469-480. PMID: 17081971